Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3983530
Max Phase: Preclinical
Molecular Formula: C44H48ClN7O6S
Molecular Weight: 838.43
Molecule Type: Small molecule
Associated Items:
ID: ALA3983530
Max Phase: Preclinical
Molecular Formula: C44H48ClN7O6S
Molecular Weight: 838.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN1CCC(Nc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CCCC5)CC4)cc3Oc3cccc4[nH]ccc34)cc2[N+](=O)[O-])CC1
Standard InChI: InChI=1S/C44H48ClN7O6S/c1-49-21-18-33(19-22-49)47-40-16-14-35(28-41(40)52(54)55)59(56,57)48-44(53)38-15-13-34(27-43(38)58-42-8-4-7-39-37(42)17-20-46-39)51-25-23-50(24-26-51)29-31-5-2-3-6-36(31)30-9-11-32(45)12-10-30/h4,7-17,20,27-28,33,46-47H,2-3,5-6,18-19,21-26,29H2,1H3,(H,48,53)
Standard InChI Key: FWBSYNQAEXSXIS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 838.43 | Molecular Weight (Monoisotopic): 837.3075 | AlogP: 8.30 | #Rotatable Bonds: 12 |
Polar Surface Area: 153.15 | Molecular Species: ZWITTERION | HBA: 10 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.15 | CX Basic pKa: 8.67 | CX LogP: 6.50 | CX LogD: 6.04 |
Aromatic Rings: 5 | Heavy Atoms: 59 | QED Weighted: 0.08 | Np Likeness Score: -1.16 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):